These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4871503)

  • 21. [Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography].
    Motomiya T
    Nihon Naika Gakkai Zasshi; 1970 Feb; 59(2):117-25. PubMed ID: 4910199
    [No Abstract]   [Full Text] [Related]  

  • 22. Ineffectiveness of isoxsuprine on intermittent claudication.
    Strandness DE
    JAMA; 1970 Jul; 213(1):86-8. PubMed ID: 4393178
    [No Abstract]   [Full Text] [Related]  

  • 23. Improved skin blood flow and cutaneous temperature in the foot of a patient with arteriosclerosis obliterans by vasopressin V1 antagonist (OPC21268). A case report.
    Toba K; Ouchi Y; Akishita M; Kozaki K; Ishikawa M; Nagano K; Etoh M; Hashimoto M; Liang J; Ueda N
    Angiology; 1995 Nov; 46(11):1027-33. PubMed ID: 7486224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.
    Motomiya T; Atsumi T; Isokane N; Yamashita S; Sano T
    Jpn Heart J; 1970 Sep; 11(5):433-49. PubMed ID: 4921577
    [No Abstract]   [Full Text] [Related]  

  • 25. [31P magnetic resonance spectroscopy: a noninvasive method for studying skeletal muscle metabolism in patients with arteriosclerosis obliterans of the vessels of the lower extremities and for assessing the efficacy of vasoprostan therapy].
    Sinitsyn VE; Veselova TN; Bakharev AO; Karpov IuA
    Ter Arkh; 1996; 68(12):69-72. PubMed ID: 9054047
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of vasodilators in peripheral arterial insufficiency].
    Hansteen V; Lorentsen E
    Tidsskr Nor Laegeforen; 1971 Aug; 91(24):1731-4. PubMed ID: 5111131
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic acquisitions on chronic obliterating peripheral arterial diseases of the lower limbs].
    Guagliano G; Bagliani A; Borri P
    Minerva Med; 1976 May; 67(25):1648-55. PubMed ID: 778666
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experiences with the vascular action of dihydroergocristine].
    Tomasi AM; Baggioni GF; Pozzar C
    Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of effect of cyclandelate in peripheral arterial disease.
    Vyden JK; Nagasawa K; Kanazawa M; Rose HB; Seino Y; Groseth-Robertson MF; Lander EB; Elconin SB
    Angiology; 1984 Jan; 35(1):1-11. PubMed ID: 6364892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal treatment of arterial insufficiency in the lower extremities.
    Albrechtsen O; Barfod B; Barfod E; Laursen NP; Nordentoft B; Yde H
    Dan Med Bull; 1972 Jul; 19(5):157-9. PubMed ID: 5049043
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of the action of p-chlorophenoxy alpha-isobutyrate of 3-hydroxymethyl pyridine hydrochloride on peripheral circulation. Rheographic and radioisotope studies].
    Modica G; Ferrante R
    Minerva Cardioangiol; 1973 Dec; 21(12):769-74. PubMed ID: 4592148
    [No Abstract]   [Full Text] [Related]  

  • 32. The late effects of lumbar sympathectomy on blood flow in the foot in the presence of occlusive arterial disease.
    Gillepsie JA
    Scand J Clin Lab Invest Suppl; 1967; 99():219-21. PubMed ID: 6060735
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
    Regenthal R; Voigt H; Reuter W; Preiss R
    Z Gesamte Inn Med; 1991 Apr; 46(6):185-90. PubMed ID: 2063598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
    Bielawiec M; Lukjan H; Grabowski R; Myśliwiec M; Korfel B
    Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
    [No Abstract]   [Full Text] [Related]  

  • 35. Iloprost and peripheral arterial disease in diabetic patients.
    Vicari AM; Chiesa R; Mari G; Galimberti M; Di Carlo V; Pozza G
    Acta Diabetol Lat; 1991; 28(1):113-4. PubMed ID: 1713729
    [No Abstract]   [Full Text] [Related]  

  • 36. On arterial reconstruction in severe ischemia of the foot.
    Bellman S; Kövamees A
    Acta Chir Scand Suppl; 1966; 357():273-6. PubMed ID: 5227091
    [No Abstract]   [Full Text] [Related]  

  • 37. [Physical and exercise therapy of chronic obliterating arteriopathy of the lower limbs: clinical study].
    Galante M; Franchignoni F; Andina A; Grioni G
    Clin Ter; 1982 May; 101(4):357-62. PubMed ID: 7105641
    [No Abstract]   [Full Text] [Related]  

  • 38. [Testosterone treatment of obliterative arterial lesions in the legs].
    Hvidt V; Dohn K; Lund J; Nielsen J; Palm L
    Ugeskr Laeger; 1965 Sep; 127(36):1116-23. PubMed ID: 5869540
    [No Abstract]   [Full Text] [Related]  

  • 39. Conservative treatment for patients with intermittent claudication.
    Sugimoto I; Ohta T; Ishibashi H; Iwata H; Yamada T; Tadakoshi M; Hida N; Orimoto Y
    Int Angiol; 2010 Apr; 29(2 Suppl):55-60. PubMed ID: 20357750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent claudication and peripheral pulses in older people.
    Milne JS; Williamson J
    Age Ageing; 1972 Aug; 1(3):146-51. PubMed ID: 4669873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.